SEHK:3613Pharmaceuticals
Beijing Tong Ren Tang Chinese Medicine (SEHK:3613) Stock Faces Margin Squeeze And Rich P E
Beijing Tong Ren Tang Chinese Medicine closed at HK$6.50 today after a flat week and a weak three month run, yet the latest half year numbers pull your attention to a different question. The headline is margin pressure. H1 2026 basic earnings per share of HK$0.24 on revenue of HK$601.9m leave trailing twelve month net income of HK$360.6m, while the stock still trades on a P/E of 15.1x against a peer average of 11.5x. The gap between price, profits and expectations is where this earnings story...